DOES CIGARETTE SMOKING, WHEN COMBINED WITH NAFLD, ALTER THE EXPRESSION OF CYP2D AND CYP2C?

被引：0
|
作者：
Pilote, S. [1 ]
Thibauilt, C. [1 ]
Jubinville, E. [1 ]
Routhier, J. [1 ]
Morissette, M. C. [1 ]
Drolet, B. [1 ]
Simard, C. [1 ]
机构：
[1] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-122
引用
收藏
页码：S87 / S88
页数：2
相关论文
共 50 条
  • [41] The ontogeny of hepatic CYP3A, CYP2C and CYP2E enzyme activity in conventional pigs
    Millecam, J.
    Devreese, M.
    De Bock, L.
    Van Bocxlaer, J.
    Gasthuys, E.
    De Backer, P.
    Croubels, S.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2015, 38 : 48 - 49
  • [42] Nifedipine Does Not Alter the Pharmacokinetics of Venlafaxine Enantiomers in Healthy Subjects Phenotyped for CYP2D6, CYP2C19, and CYP3A
    Tozatto, Eduardo
    Benzi, Jhohann Richard de Lima
    Rocha, Adriana
    Coelho, Eduardo Barbosa
    Lanchote, Vera Lucia
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (03): : 319 - 327
  • [43] Structure and function of a novel CYP2D enzyme, CYP2D30 from marmoset liver: Comparison with CYP2D19
    Hichiya, H
    Kuramoto, S
    Yamamoto, S
    Asaoka, K
    Miyata, A
    Narimatsu, S
    DRUG METABOLISM REVIEWS, 2003, 35 : 104 - 104
  • [44] CYP2D6 genotype and smoking behaviour in cigarette smokers
    Boustead, C
    Taber, H
    Idle, JR
    Cholerton, S
    PHARMACOGENETICS, 1997, 7 (05): : 411 - 414
  • [45] Effect of cigarette smoking on CYP2C9 activity.
    Kim, M
    LaCourse, J
    Nafziger, AN
    Wallace, AL
    Kashuba, AD
    Rowland, E
    Gaedigk, A
    Bertino, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P14 - P14
  • [46] TRANSCRIPTIONAL REGULATION OF HUMAN CYP2C GENES - FUNCTIONAL COMPARISON OF CYP2C9 AND CYP2C18 PROMOTER REGIONS
    IBEANU, GC
    GOLDSTEIN, JA
    BIOCHEMISTRY, 1995, 34 (25) : 8028 - 8036
  • [47] Torsemide metabolism by CYP2C9 variants and other human CYP2C subfamily enzymes
    Miners, JO
    Coulter, S
    Birkett, DJ
    Goldstein, JA
    PHARMACOGENETICS, 2000, 10 (03): : 267 - 270
  • [48] Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver
    Chow, T
    Imaoka, S
    Hiroi, T
    Funae, Y
    DRUG METABOLISM AND DISPOSITION, 1999, 27 (02) : 188 - 192
  • [49] Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity
    Wan, J
    Imaoka, S
    Chow, T
    Hiroi, T
    Yabusaki, Y
    Funae, Y
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 348 (02) : 383 - 390
  • [50] Interferon-β treatment in patients with multiple sclerosis does not alter CYP2C19 or CYP2D6 activity
    Hellman, K
    Roos, E
    Österlund, A
    Wahlberg, A
    Gustafsson, LL
    Bertilsson, L
    Fredrikson, S
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (03) : 337 - 340
12345